NCT01694693View on ClinicalTrials.gov

Description of Joint Population and Assessment of Impact on Health Status of Orencia in Patients With Rheumatoid Arthritis in France. A Database Analysis Based on SFR's ORA Long-term Cohort Study

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

January 31, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Orencia

No Intervention

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01694693 - Description of Joint Population and Assessment of Impact on Health Status of Orencia in Patients With Rheumatoid Arthritis in France. A Database Analysis Based on SFR's ORA Long-term Cohort Study | Biotech Hunter | Biotech Hunter